.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Hearing care provider Hearzap recently announced the acquisition of Amplifon India. This significant move marks a major shift for hearing healthcare in India as the company scales its operations. Supported by 360ONE Asset Management, the deal integrates Amplifon’s extensive network into Hearzap's growing portfolio. Consequently, the merger is set to enhance clinical standards and service availability across the nation.
The acquisition adds approximately 240 points of sale to Hearzap's existing infrastructure. As a result, the combined entity will operate a total of 430 points of sale. This expansion allows the company to tap into a broader demographic, ranging from pediatric to geriatric patients. Furthermore, the merger brings together nearly 1,000 service providers to offer comprehensive audiology solutions.
Hearzap aims for a topline revenue of ₹250 crore by the end of the current financial year. Specifically, the integration focuses on deep investments in audiology talent and technological innovation. Founder S Raja emphasized that this scale will lead to better healthcare outcomes for patients nationwide. Moreover, the company expects to reach 500 hearing care centers by 2027 to meet the rising demand.
Q1: What is the primary goal of Hearzap’s acquisition of Amplifon India?
The acquisition aims to expand Hearzap's national footprint and strengthen hearing healthcare in India through combined expertise and points of sale.
Q2: What is the projected network size of Hearzap by 2027?
Hearzap expects its network footprint to approach 500 hearing care centers across India by 2027 to ensure widespread accessibility.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Hearzap acquires Amplifon India to expand its network to 430 centers, targeting ₹250 crore revenue by FY25 and aiming for 500 centers by 2027....
5 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
